2018
DOI: 10.1016/j.biocel.2017.11.011
|View full text |Cite
|
Sign up to set email alerts
|

Splenomegaly: Pathophysiological bases and therapeutic options

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

7
40
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 73 publications
(60 citation statements)
references
References 25 publications
7
40
0
Order By: Relevance
“…Furthermore, the enlargement of red and white pulp elements accompanied by the loss of the atypical structure of the germinal center (GC) leads to splenomegaly [77]. In animal models, splenomegaly can also arise as a physiologic response to stressors, and the increase in spleen size was associated with splenic extramedullary hematopoiesis (EMH) [16]. Additionally, disruption of the normal splenic architecture by a diffuse infiltrate predominantly expanded the white pulp.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Furthermore, the enlargement of red and white pulp elements accompanied by the loss of the atypical structure of the germinal center (GC) leads to splenomegaly [77]. In animal models, splenomegaly can also arise as a physiologic response to stressors, and the increase in spleen size was associated with splenic extramedullary hematopoiesis (EMH) [16]. Additionally, disruption of the normal splenic architecture by a diffuse infiltrate predominantly expanded the white pulp.…”
Section: Discussionmentioning
confidence: 99%
“…The spleen serves as a hematopoietic and secondary lymphoid organ in mice. It is the largest immune organ in the body and is also necessary for homeostasis and iron recycling of red blood cells [16]. Many gastrointestinal diseases—such as coeliac disease, chronic atrophic gastritis, and inflammatory intestinal illness—may trigger splenic disorders (e.g., splenomegaly) as secondary symptoms because they possess similar pathophysiology [17].…”
Section: Introductionmentioning
confidence: 99%
“…ADM treatment remarkably reduced this effect of DNCB without significant alteration in body weight in comparison with the normal control group. The spleen is one of the most important immune organs, and spleen enlargement is usually associated with infection and inflammatory diseases [ 22 ]. In the present study, DNCB induced AD-like symptoms and increased spleen weights; in contrast, ADM treatment suppressed these phenomena.…”
Section: Discussionmentioning
confidence: 99%
“…The spleen is a complex organ, and size can increase or decrease rapidly depending on many factors, not all to do with the patients' recorded clinical information; the spleen can augment its size more than any other organ due to drugs or infection . The spleen is an organ that increases in size (splenomegaly) due to a variety of pathologies because of the reactive proliferation of the reticuloendothelial (lymphocyte) cells . Splenomegaly can also be present in lymphoma, portal hypertension, cirrhosis and collagen storage diseases, and the estimation of spleen size is essential for treatment and prognosis .…”
Section: Discussionmentioning
confidence: 99%
“…The spleen is an organ that increases in size (splenomegaly) due to a variety of pathologies because of the reactive proliferation of the reticuloendothelial (lymphocyte) cells . Splenomegaly can also be present in lymphoma, portal hypertension, cirrhosis and collagen storage diseases, and the estimation of spleen size is essential for treatment and prognosis . Therefore, it is a possibility that a flux of spleen size may conceal wide variations in operator error across repeated measurements, particularly as measurements were taken at six‐monthly or yearly intervals.…”
Section: Discussionmentioning
confidence: 99%